{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:11:15Z","timestamp":1773292275271,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.bcmd.2008.11.002","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T05:06:28Z","timestamp":1232687188000},"page":"159-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Promising results of the chaperone effect caused by iminosugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease"],"prefix":"10.1016","volume":"42","author":[{"given":"Gessam\u00ed","family":"S\u00e1nchez-Oll\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meritxell","family":"Egido-Gab\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Casas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Lluch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Chab\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00efsa","family":"Vilageliu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2008.11.002_bib1","first-page":"3635","article-title":"Gaucher disease","volume":"Vol. III","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bcmd.2008.11.002_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410420412","article-title":"Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease","volume":"42","author":"Schiffmann","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcmd.2008.11.002_bib3","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2008.11.002_bib4","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"Enquist","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2008.11.002_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jgm.901","article-title":"AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease","volume":"8","author":"Mceachern","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.bcmd.2008.11.002_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2006.07.002","article-title":"RNAi-mediated inhibition of the glucosylceramide synthase (GCS) gene: a preliminary study towards a therapeutic strategy for Gaucher disease and other glycosphingolipid storage diseases","volume":"37","author":"Diaz-Font","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2008.11.002_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","article-title":"A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity","volume":"24","author":"Fan","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bcmd.2008.11.002_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/cmdc.200600195","article-title":"Chemical tools to investigate sphingolipid metabolism and functions","volume":"2","author":"Delgado","year":"2007","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.bcmd.2008.11.002_bib9","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2008.11.002_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bcmd.2005.05.007","article-title":"Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations","volume":"35","author":"Alfonso","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2008.11.002_bib11","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.bcmd.2008.11.002_bib12","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2008.11.002_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","article-title":"N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcmd.2008.11.002_bib14","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bcmd.2008.11.002_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/jm060677i","article-title":"Isofagomine- and 2,5-anhydro-2,5-imino-d-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention","volume":"50","author":"Yu","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcmd.2008.11.002_bib16","doi-asserted-by":"crossref","first-page":"13192","DOI":"10.1073\/pnas.0705637104","article-title":"Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease","volume":"104","author":"Zheng","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2008.11.002_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nchembio850","article-title":"Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease","volume":"3","author":"Lieberman","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcmd.2008.11.002_bib18","unstructured":"N.J. Weinreb, A phase 2 clinical trial of the pharmacological chaperone AT2101 for the treatment of Gaucher disease. 8th European Working Group on Gaucher Disease (EWGGD) Meeting. Budapest; 2008:43."},{"key":"10.1016\/j.bcmd.2008.11.002_bib19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1039\/B411473F","article-title":"New aminocyclitols as modulators of glucosylceramide metabolism","volume":"3","author":"Egido-Gabas","year":"2005","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bcmd.2008.11.002_bib20","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1016\/S0040-4020(01)86715-6","article-title":"A facile transformation of sugar lactones to azasugars","volume":"50","author":"Overkleeft","year":"1994","journal-title":"Tetrahedron"},{"key":"#cr-split#-10.1016\/j.bcmd.2008.11.002_bib21.1","unstructured":"J.W. Kelly, A.R. Sawkar, E. Beutler, C.H. Wong, W.E. Balch, Chemical chaperones and their effect upon cellular activity of beta-glucosidase, WO 2004\/037373 A2"},{"key":"#cr-split#-10.1016\/j.bcmd.2008.11.002_bib21.2","unstructured":"The Scripp Research Institute (2004) 54."},{"key":"10.1016\/j.bcmd.2008.11.002_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20043","article-title":"Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: pathogenic changes and \u201cmodifier\u201d polymorphisms","volume":"23","author":"Montfort","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcmd.2008.11.002_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jmg.32.9.740","article-title":"Unusual expression of Gaucher's disease: cardiovascular calcifications in three sibs homozygous for the D409H mutation","volume":"32","author":"Chabas","year":"1995","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcmd.2008.11.002_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2008.11.002_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1098-1004(1998)11:4<295::AID-HUMU7>3.0.CO;2-6","article-title":"Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome","volume":"11","author":"Cormand","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bcmd.2008.11.002_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bcmd.2005.04.007","article-title":"Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]\/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease","volume":"35","author":"Chabas","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2008.11.002_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2008.11.002_bib28","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1046\/j.1432-1327.2000.01457.x","article-title":"In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives","volume":"267","author":"Asano","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcmd.2008.11.002_bib29","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcmd.2008.11.002_bib30","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1074\/jbc.M308523200","article-title":"Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients","volume":"279","author":"Tropak","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2008.11.002_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbadis.2007.02.003","article-title":"Enzyme enhancement activity of N-octyl-beta-valienamine on bete-glucosidase mutants associated with Gaucher disease","volume":"1772","author":"Lei","year":"2007","journal-title":"Biochim. Byophis. Acta"},{"key":"10.1016\/j.bcmd.2008.11.002_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cbpa.2007.05.035","article-title":"Gaucher disease","volume":"11","author":"Butters","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bcmd.2008.11.002_bib33","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/cmdc.200700061","article-title":"Aminocyclitols as pharmacological chaperones for glucocerebrosidase, a defective enzyme in Gaucher disease","volume":"2","author":"Egido-Gabas","year":"2007","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.bcmd.2008.11.002_bib34","doi-asserted-by":"crossref","first-page":"29052","DOI":"10.1074\/jbc.M705005200","article-title":"Crystal structures of complexes of N-butyl- and N-nonyl-deoxynojirimycin bound to acid beta-glucosidase: insights into the mechanism of chemical chaperone action in Gaucher disease","volume":"282","author":"Brumshtein","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2008.11.002_bib35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/prot.21554","article-title":"An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase\u2013substrate interactions \u2014 relevance for Gaucher disease","volume":"70","author":"Atrian","year":"2008","journal-title":"Proteins"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979608002209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979608002209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:25:10Z","timestamp":1761049510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979608002209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1079979608002209"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2008.11.002","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising results of the chaperone effect caused by iminosugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2008.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}